Skip to main content
. 2022 Apr 13;14(8):1949. doi: 10.3390/cancers14081949

Table 5.

Disease-free survival (DFS) and overall survival (OS) in early-stage NSCLC with high TMB.

Study Year Kind of Study Nr of Patients DFS OS
Devarakonda et al. 2018 Prospective 908 n.r.* positive
Tian et al. 2020 Retrospective 1026 positive n.s.
Owada-Ozaki et al. 2018 Retrospective 90 n.s. negative

* n.r.: not reported. n.s.: not significant.